No title
Tuberculosis (TB) and other mycobacterial infections have become more difficult to treat since the strains need to be screened for resistance. Furthermore, the half-year long treatment time could harm hepatocytes as a side effect of the treatment. This calls for discovery of new compounds for a successful treatment. One such promising peptide was recently discovered and called NZX. In this study
